i've been impressed over the years of the fda but the gold standard of fda which was established at least six years ago with the phone my channel was that this agency was to take a look tat drugs that were about to go on the market in america and conduct tests as questions, do their own research to determine two things that are they safe and are they effective? safe and effective. that's it but it's a lot. so over the years from 60 years or more have used those standards to judge drugs, clinical trials which carefully measure the impact of the drug on the human body . over a training time in the life is frustrating because at times it takes longer than we wish. there are exceptions that have been created at the fda for extraordinary circumstances where they can accelerate the process. but by and large they have judge drugs are safe and effective . today, nearly 3/4 of drugs are approved in the united states by the fda before they are approved in any other country around theworld . the fda is considered the gold standard, i've been told that so many times and in many countries, the fda and

since then -- of the fda and cdc. since then, we have performed a number far greater than any other country and doubled the per capita tests performed to date in south korea. we implement it a phased approach to meet testing needs during mitigation, and now during phase i one reopening of america. pioneeredmarch 20, we 41 community-based drive-through testing sites in locations prioritized by the cdc with profound success, testing over 167 thousand high-risk individuals and demonstrating a prototype that is being duplicated multi fold in nearly every state. leveragedministration trusted retailers, including aid, whoreens, rite are now providing testing in 33 states, 69% of which are in committed bees with moderate to high social phone or ability. to meet the need for collection supplies like swabs and media tubes, we first secured the global supply chain through a military air bridge. we worked directed with manufacturers to increase mastic production. we collaborated with the private sector and the fda to validate mu

the fda has worked with 500 developers and said they will have the covid-19 test. this includes some newer technologies that heretofore have not been used as part of diagnostic test in response to a pandemic. we have issued 92 individual emergency use authorizations for test kit manufacturers and laboratories and we've been informed by more than 250 laboratories they have begun testing under the regulatory flexibilities we outlined in march. we are conducting rolling reviews at ua submissions so that we can quickly authorize tests in which the data support. in a public health emergency the accuracy of diagnostic tests is important not only for the individual patient, but for the patient at large and the public at large. the availability of tests that are providing accurate answers and we are also monitoring the marketplace for fraudulent tests and are taking appropriate action to protect the public health and we are working to provide more clarity about which tests have been reviewsed and authorized by fda and which have not. serologic tests will play a role in our

i think you would rile on yr hhs,dc and your fda. i know you're looking at other i think if you wresident you would be behind the scene asking these same questions and now you're doing it publicly to question, but it goes this distrust in the institutions which makes people even more confused and more scared. >> unfortunately, i do distrust the institions because i've seen them fail. and they are not gods. but they are part of the class of people thate think they smarter than everyone else. theyertainly think they are iarter than just mere doctors. and sometimeshink the mere doctors who are closer to the scene are smarter. >> so let's talk about governor cuomo has said by may 15th in a veryhad and methodical way, new york will begin to open up some of its businesses, some of the economy will begin to return. while new york is the hardest kit, a recent study by the investment b raymond james has found that only four states, kansas, montana, washington, and wyoming, meet all of the criteria from the whiteouse reopening guidelin. >> rig

new questions about the fda.he president's politics influencing the agency that was supposed to be approving drugs and moving things forward because of science alone? you wouldn't accept an incomplete job from anyone else. why accept it from your allergy pills? flonase sensimist. nothing stronger. nothing gentler. nothing lasts longer. flonase sensimist. 24 hour non-drowsy allergy relief when bugs move in we stress out and spray. well, we used to. new ortho home defense max indoor insect barrier kills and prevents bugs for up to a year without odors, stains or fuss. new ortho home defense max. bugs gone. stress gone. ♪[ siren ] & doug give me your hand! i can save you... lots of money with liberty mutual! we customize your car insurance so you only pay for what you need! only pay for what you need. ♪ liberty. liberty. liberty. liberty. ♪ are your asthma treatments just not enough? then see what could open up for you with fasenra. it is not a steroid or inhaler. it is not a rescue medicine or for other eosinophili

fda is helping to ensure the availability of tests that are providing accurate answers.e are also monitoring the marketplace for fraudulent tests and are taking appropriate actions to protect the public health. and we are working to provide more clarity about which tests have been reviewed and authorized by fda and which have not. serologic tests will play a role in our recovery, unlike diagnostic tests, they measure the amount of antibodies of protein in the blood. these tests can identify individuals who can overcome an infection and have developed an immune response. we'll work with labs, manufacturers and across the government to find a balance between the assurance that an antibody test is accurate and timely access to such tests. of course, the way we will eventually beat this virus is with a vaccine and the fda is working with our federal partners, including the nih, vaccine developers, manufacturers, and experts across the globe. we intend to use our regulatory flexibility to help ensure the most efficient development of a safe and effective vaccine to prevent co

tell us more on what the fda is saying?nowledgement by the fda that the initial regulations, the initial oversight was not strong enough to stop bogus operators, bogus people coming in and making tests that were simply worth nothing. they simply worth nothing. they simply didn't do the job stop they were fraudulent and some 170 firms came forward with these antibody tests, test, the blood test which would determine whether someone has an immunity to coronavirus. moving forward, the fda says these companies, and there are far fewer now, there's a website where the fda is listing those approved companies. they have within ten days to submit their data for some independent oversight. whereas before, it was essentially soft verification based on their own data and no independent oversight. so much tighter regulatory framework moving forward for these antibody tests that are much—needed by so many people. and that is one of the claims by the fda that these operators have simply been exploiting the fears of americans at this time

the fda has set up a way to do those trials quickly. what we need to have happen is more hospitals using their electronic data systems to do these studies in the same way. so that more people can get enrolled and we can keep the time of completing those trials to be as short as possible. some of the so-called platform trials are being set up and the national institutes of health is starting to run them now. we'd like to see those be much more widely available. >> so dr. mcclellan, president trump calling a clinical study of hydroxychloroquine in va patients phony. he is taking the drug against the fda's recommendations. he's sidelining the cdc. what impact do these attacks have on fighting this pandemic? >> well, i hope they won't slow down the need to get more evidence on the treatments that really work. there are some randomized studies under way now about hydroxychloroquine that will hopefully give us more definitive evidence. for now, though, don there is not clear evidence this treatment works and the fda has put out some very clea

i am pleased to announce gilead has leeway from the fda for remdesivir. you know what that is because that has also been the hot thing in the papers and the media for little while. an important treatment for hospitalized coronavirus patients, and something -- i spoke with dr. hahn, dr. fauci and i spoke with deborah about it. it is a promising situation. we have been doing work with the teams in the n.i.h. and gilead, spearheading this process to make it happen quickly. so today, we are going to -- i will do it, we will let dan state and as to what the company is doing, making a contribution to really people that are not doing well, people that are sick, people that have this horrible plague that has set into our country. and we are getting rid of, and we are going to be having some really incredible results. we have very promising studies coming out of the vaccines. promising studies coming out on the therapeutics. first one is from dan and gilead. i would like to maybe have you say a few words as two, number one, about remdesivir to start off with, and

again, against the fda's guidance. thank you, john. >>> the president defying medical warnings and announcing he's taken this unproven drug, hydroxychloroquine to try to ward off coronavirus. elizabeth cohen is with us. the president -- it wasn't even admission, just sort of a bold pronouncement that he's taking it. but for every american watching who thinks maybe they should do the same, what do they need to know? >> they need to know to not do it. they have a choice, they can listen to president trump who has been an anti-science president, or they can listen to tony fauci, number one, the national institutes of health number two and the food and drug administration number three. that's their choice. right? now, first of all, you have to get your doctor to prescribe it, and i am hoping that doctors out there in the united states are not going to give in to pressures of patients and prescribe it. president trump's doctor, it appears, did give in to pressure from his patient, the president of the united states. it is a

fda has woshlrked to facilitatee development of our members to work on covid-19. we have worked with manufacturers, product developers, our federal partners and companies, companies that don't even make medical products but want to chip in, for example, by making hand sanitizer, personal protective equipment and ventilators. every decision we have made have been driven by data with the goal of protecting the health of the american people. in a public health emergency, however, our response is the urgent need to make medical products available with a provision of oversight that helps ensure the safety and effectiveness of those medical products. i'd like to take a few minutes to tell you what the fda is doing to help the country at this point which makes america safe to return to work and to school. it starts with testing, as others have mentioned. the fda has worked with more than 500 developers who said they have or will be submitting requests for covid-19 tests. this includes some newer technologies that heretofore have not been used in response to a diagnostic

you know, the thing here, this is a direct contradiction of the fda ops own guidan fda's own guidance they issued in april. hydroxychloroquine shouldn't be used outside of a clinical setting where they can check your heart rhythm, things of that nature. there are questions, is the president contradicting his own fda here by announcing he's been taking this for a week-and-a-half now. >> is there any acknowledgment that -- yeah, i know there is no actual knowledgement. as you said, his own fda has warned against this drug. you know, assuming he's taking it, i'm wondering is part of him taking it just, you know, him wanting to show that he doesn't listen to, you know, doctors or scientists or sound medical advice or studies because he's been touting this so long that now he's just being resistant? i mean, i don't know. it makes -- logically, i don't understand why he would be taking this. >> reporter: well, there was a little period there where he stopped touting it to sochb to where we asked him in the briefing why he stopped talking about it so much because for weeks he had been pushin

>> sir, the payment is not a responsibility of the fda. i share your concern that this needs to be made available to every american. >> does anybody else want to comment on that? mr. giroir, do you think we should make that vaccine when it is created available to all regardless of income, or do you think poor and working people should be last in line for the vaccine? >> i'm sorry, senator, were you asking me? >> yes, i was, sir. yes, i was. >> no, i -- my office is one of the offices committed to serving the underserved and we need to be absolutely certain that if a vaccine or an effective therapeutic or preventive is available that it reaches all segments regardless of their ability to pay or any other social determineants of health that there may be. >> good. so what you're telling the american people today regardless of income, every american will be able to gain access to that vaccine when it comes? >> they should gain access to it. >> you represent an administration that makes that decision. >> i will certainly advocate that everyone

either way for the fda for remdesivir. you know what that is because that's been the hot thing in the papers and in the media for little while. an important treatment for hospitalized corona patients and something i spoke with dr. kohn, dr. fauci come i spoke with deborah about it. it is really a really promising situation. we have been doing work with the teams and the fda, nih, gilead for spearheading this private public partnership to make this happen quickly. so today, we are going to be -- i will let dan do it, but i will let dan tell us what he's doing to make a contribution to really people that are not doing well. people that are sick. people that have this horrible plague set into our country. and that we are getting rid of and we are going to be having some really incredible results. we have very promising studies coming out on the faxing. we have promising studies coming out on therapeutics. the first one is from dan and gilead. i would like to maybe have you say a few words, dan. and also the contribution being

there are no fda authorized at home antibody tests. the existence of antibodies proven someone has been exposed and while health experts believe they could provide protection from the virus, so far they don't know for sure. >> it's certainly worthwhile if you're conducting studies in a given town to know people that have been infected with the virus. >> reporter: it's good for research i doesn't punch my ticket to go walk out on the streets and do whatever i want. >> that's right. we still don't know what being antibody positive means. >> reporter: in south korea there were reports of people being reinfected now health officials say there were errors on testing but with uncertainty remaining about antibodies, finding a vaccine is more important. >> i think we'll have a vaccine by the end of the year the doctors would say well, you shouldn't say that i'll say what i think. >> reporter: there are promising signs. six vaccines areand dozens morn development.ng vaccine himself worries that trying to speed up the process may sacrifice the p

fda is listing those approved companies.submit their data for some independent oversight. whereas before, it was essentially soft verification based on their own data and no independent oversight. so, much tighter regulatory framework moving forward for these antibody tests that are much—needed by so many people. and that is one of the claims by the fda that these operators have simply been exploiting the fears of americans at this time, during the pandemic, their fears of this virus and their desperate need to get a test. and yet, peter, even with fda oversight, there are still concerns out there about accuracy? yes, that is the problem, that they are not 100% accurate. moving forward, what the fda are saying is that the number of true positives, those positive tests that really are accurate and correct, should be at least 90% of them. 95% of them if they are true negatives. that does leave a little gap, not 100%, of uncertainty. and i think it's true to say that these tests are good as population surveys with large samples

in the fdaed assured them they d everything under control. they should by staff have covered the issues might come into play when you're having a partnership with somebody else. fda is promoting the idea having theoo doors open for developerso submit data and to seek approval treatments and vaccines. until we have a vaccine, helping will be gradual. we need final solutions for the saga we are going through. but we cannot afford bureaucratic obstacles slowing down regulatory approvals for successful vaccine. as we have seen, certain steps, vaccine development can be achieved at warp speed to o cut down on development time, regulatory approvals will not be one of them honestly take legislative action. it's real action emma not just talk, specifically designed for times like this. when scientists across the world are racing to develop treatments and vaccines. therefore, with my prior objection, i do not want to leave my friend from illinois empty-handed. in helping my colleague from illinois will not object, madam president as the sands the legi

the fda has given emergency use authorization. where are you all in the study, and how far, potentially, from an fda full-out approval? >> so this wonderful nih adaptive clinical trial developed by our wonderful scientists will adapt now to look at remedesivir with medications that modulate the immune system, meaning it controls some of the in inflammation the virus creates and we'll see if it reduces the symptoms and also the mortality of patients that have covid-19. we're waiting to hear more information from the fda as to how they will consider remedesivir moving beyond the emergency use authorization to potentially eventual approval. in the interim we also are interested in offering not only the study but every therapeutic option we have for all of our patients to make sure we are really getting them home to their families as quickly as we can. >> can i ask you a broad question, broader from the treatment of remedesivir, about the potential vaccine. dr. anthony fauci, along with the lead scientist at the nih for research, they

the fda has said this should not be used outside of clinical trials. there is a clinical trial for proef lax is on workers who have had a lot of exposure. i think people will go out and start hoarding this medication and there are people who use it for legitimate regions. th -- reasons. >> what do you think, dr. bessler? >> the fda is a trusted source of information for what drugs are safe and effective. i worry that people will hear and think there is evidence that this works and that people could be harmed because all drugs have side effects, people with other medications, people who take this could be harmed by it. it is not a good thing for the general public to do. let's see what these studies do in terms of prevention. >> it is an effective drug, dr. boeser are y. are you worried with the president it outing it, people will rush out and get it and those who need it might not get it? >> we saw that in 2001, after the anthrax letters were sent. there was a rush on those. hoarding is a fphenomenon. people say he must know something we don't know. th

as you said, his own fda has warned against this drug. assuming he's taking it, i'm wondering is part of him taking it just, you know, him wanting to show that he doesn't listen to, you know, doctors or scientists or sound medical advice. or studies. because he's been touting this so long that, now, he's just being resistant? i mean, it makes -- logically, i just don't understand why he would be taking this. >> well, there is a little period there where he stopped touting it so often. to where we even asked him in the briefing why he had stopped talking about it so much. because, for weeks, he had been pushing it saying this sentiment, you know, what do you have to lose? which is what he said today. and then he kind of went quiet on it after you saw several studies from that journal, va study, the fda guidance talking about how there is no proof that it works or that it helps in any way. and actually, it can be harmful if you do have coronavirus and other underlying health conditions. but, then -- you know, the president said today he's b

but why then go through that process without going to the fda back in march? >> right so we shifted and immediately allocated all of our test kits to hospitals and front line workers, we shipped out over 35,000 tests. the reason why we developed the at-home test originally back in march was because we saw this need to work with these and had filed for their emergency use authorization and be able to get testing into the home to conserve ppe to reduce exposure to help flatten the curve. at the time the fda guidelines were different and so once they clarified that on march 20th, we didn't launch on march 23rd. that's why we have been able to creppiate there great partnership with the fda. we are highly committed over the last few months. >> thank you so much for your time this morning. >> thank you for having many e. >> sure. >>> some breaking overnight, you want to see this horrific scene in downtown los angeles, four firefighters are in intensive care this morning after what is being described as a massive explosion. we will take you live to that scene. stay c

quote, the fda is aware of reports of serious heart rhythm problems in patients with covid-19 treated with hydroxychloroquine or chloroquine. additionally, quote, hydroxychloroquine and chloroquine have not been shown to be safe and effective for treating or preventing covid-19. those first words bear repeating. serious heart rhythm, heart problems in patients with he covid-19 treated with hydroxychloroquine and chloroquine. and a study published days ago in the

the fda's nod came after dr. anthony fauci, the nation's top infectious disease expert showed that the trial data showed that the drug had a clear cut significant positive effect in diminishing the time to recovery. we should note this does not mean the drug should be used for all hospitalized patients. previous research suggested the drug may have potentially dangerous side effects in some patients. but the maker of remdesivir, gilead sciences, is hoping that they can expand the drug's use for patients earlier in the course of their illness. here's the ceo of gilead sciences on the "today" show. >> we were prepared and ready for this virus because of some of the work we've done with remdesivir for the past decade. at the same time that we put remdesivir in the clinical trials, we also made the decision before knowing it was going to be effective, to expand our capacity knowing the global crisis this was and knowing we would have to be ready in the event that this turned out to be effective for patients. so we ha

it was something that is statistically significant, so that's why the fda, you saw the head of the fda, dr. hahn in there, sort of fast tracked this, give this the green light because in essence here, the doctors saw what they needed to see with remdesivir, something that had been used a handful of years ago in the fight against ebola, now working in hospitals on patients for covid-19, and the hope is that if you're one of those patients that has to go in to the hospital, unfortunately, once you get there, this drug from gilead now will not only help but help you get out of the hospital quicker than you might otherwise would have stayed in there. connell? connell: yeah, positive developments indeed. all right. blake, thank you. blake burman in washington. melissa has more now. melissa: all right. here now to react is steve forbes, forbes media chairman. steve, what do you think about this? this is the ingenuity of a private company. they donated the drug as you heard there. what are your thoughts? >> well, i think this underscores the importance of the private sector, and i'm delighted

this all comes amid the fda warning about the drug. the risk of heart rhythm problems. the fda saying the drug should not be taken for coronavirus outside a hospital or clinical trial. our chief white house correspondent jonathan karl on what he's learned about the president, and what he says he's now taking. >>> the other headline tonight involves potentially promising news in the race for a vaccine here in the u.s. tonight, what the company now says the early trials are showing. >>> reopening america. all 50 states partially reopening this week. the crowds on beaches. packed bars and restaurants. leading to questions about being cautious, keeping a safe distance. and tonight, america's big three automakers back online. what some workers shouted at the cameras. some saying they should not be returning to work. others saying it's the risk they have to take to get paid, to put food on the table. tonight, the images. the temperature checks. other measures inside those factories. and the numbers out of texas. after reopening, it's the biggest one-day spike in cases over th

is there blame in that and is it at risk at the fda. >> fda gets criticized.t criticized for letting on a lot of the new antibody tests. it sounds like from your symptoms and what you went through, i'm pretty sure you are immune for now. many of the tests on the market have not given accurate results. fda took steps over this past week to tighten that up backed by new research and new testing that's being done with support from the nih so that the goal is to get more confidence in the antibody tests that are on the market. we're not there yet though and i think people need to be careful about the antibody tests throughout and the claims they're making. >> a lot of people aric approximatiare picking them up off line. they're really quick. you can do them at home. governor abbott got a lot of traction saying birx likes my plan. he doesn't have it in place yet and yet he is reopening. it seems so obviously cart before the horse. what is your take as someone who knows the plan well in the zbhofr government? >> chris, i've written several reports about what we thin

gained the fda seal. there are some minimal standards of efficacy that are required and you must adhere to some privacy rules. recommend the fda supported apps and devices. consumers can find information at various places on the web about apps in terms of which ones are approved and which ones are shown to be efficacious and which ones are treating their data with privacy. i encourage consumers to do the research but health care providers can be a source of information on this. prussia,g of pennsylvania, and mental health professional. dr.are on with joshua gordon. caller: yes, hello. are you talking to linda? host: you are on with our guest. caller: i am a frequent viewer of c-span. i want to give a kind of recognition. licensed professional counselor, i am a therapist. we have been working really hard. itcaseload is as full as ever was because people need a lot. different styles of therapy that are effective in general. one of my favorites is muscle relaxation and meditative breathing. i see that some l

the fda and these things get political. >> all right. so we should trust -- the audience -- i think what you're saying the audience should doubt the fda -- >> don't trust me. >> and the instituti -- >> i'm not telling you to trust me. i'm not telling you to trust the president. trust your doctor. he is going to be better than the fda. >> ifen you were presof the united states i think you would rile on your hhs, cdc and your 'ra. i know y looking at other studies. i think if you were president you would be behind the scene e asking these s questions and now you're doing it publicly to sort of elevate building , questi but it goes this distrust in the institutions which makes people even more nfused and more scared. >> unfortunately, i do distrust the institutions because i've il seen them and they are not gods. but they are partf the class of people that think they are smarter than everyone el. theyertainly think they are smarter than just mere doctors. and somimes i think the mere doctors who are closer to the scene are smarter. >> so le

it's the fda. >> yes. fda, yeah. >> it's the v.a. they've done studies.ricans. also, by the way, we just have to say this. there are a lot of people with lupus. we have a good friend who has lupus and had trouble getting that medication which is for lupus. i had a top republican fund-raiser over the past several cycles, talking about a member of his family who has lupus and it's making it harder for them to get the drug for something where it actually works. let me ask you while we're talking about -- >> -- you don't even know if trump when he went onstage thought of doing this. it's whatever pops into his head at the moment and all too often it's destructive and harmful having nothing to do with solving our problems or the truth. that little shiny object that he thinks will divert attention from his failures. >> yeah. unfortunately in this case, that little shiny object, that nonsensical aside, actually puts americans who listen to him, puts their lives certainly their health in danger. >> even fox news -- >> let me ask you about vaccines. we've heard fo

obtained the internal document which cited projections from a johns hopkins university model former fda official scott gottlieb said there could be more deaths without a decrease. >> as you open the economy and people interact more, stop is social distancing, that slow burn of infection could ignite at any point. >> reporter: it comes as president trump is revising his projection for the number of lives lost two weeks ago, saying the death toll could be as long as 50,000. sunday, saying it will likely be significantly higher. >> we're going to lose anywhere from 75,000, 80,000, to 100,000 people that's a horrible thing. we shouldn't lose one person over this. >> reporter: the white house and the cdc are disavowing the draft document the white house saying it is not their document, that it's not gone through inter-agency vetting, and is not reflective of any of the modeling done by the task force the creator of the johns hopkins model telling the "washington post" the projections were not intended to be a forecast. adding, there are reopening scenarios where it could get out of control v

and does it rest at the fda? >> well, fda gets criticized on both sides. it got criticized over the last couple of months for letting on a lot of the new antibody tests. and, chris, it sounds like you got an accurate one and because of your symptoms, because of what you went through, i'm pretty sure you are immune now. but many tests on the market, especially for people who weren't symptomatic, have not given very accurate results. fda took steps over this past week to tighten that up. backed by some new research and some new testing that's being done, with support from the nih. so the goal is to get more confidence in the antibody tests that are on the market. we're not there yet, though, and i think people need to be careful about the antibody tests out there and the claims that they're making. >> yeah. a lot of people picking them up offline. same thing with covid positive/negative tests. you have been talking with governor of texas abbott. he got a lot of traction saying birx likes my plan and we are going to have more testing and all that. but he does

la fda dijo de que habÍa que eliminarlo de inmediato.es, cientÍficos, que determinan lo que sirve y no sirve. te recuerdas de un medicamento. el presidente de estados unidos en un momento dado la estuvo promoviendo y ahora despuÉs de varios estudios han dado cuenta de que es peligrosa, puede generar problemas cardÍacos. marÍa: ahí estÁ el doctor juan. jorge: vamos contigo. durante semanas hemos estado hablando sobre cÓmo afecta el coronavirusa los pulmones, pero ahora tambiÉn hay informes que afecta el intestino. cÓmo es eso? juan: hola a ambos. sabÍamos que habÍan algunos pacientes que tenÍan nÁuseas, vÓmitos, diarreas. aunque es un porcentaje bajo sabemos que el receptor donde el coronavirus se adhiere tambiÉn estÁ en las cÉlulas intestinales. eso quiere decir que explica por quÉ el virus puede provocar esos sÍntomas gastrointestinales. tambiÉn se han publicado estudios que demuestra que la infecciÓn se puede transmitir por la vÍa fecal. tambiÉn sugiere que hay virus en el tracto gastrointestinal. marÍa:sobre todo, me preocupa lo del i

the fda has said, quote, the fda cautions against use of hydroxychloroquine or chloroquine for covid-19 outside a hospital setting or clinical trial due to risk of heart rhythm problems. of course the president will be 74 years old in a couple of weeks, and according to his 2018 physical he has a common form of heart disease. and on top of all of this there is one more really important thing, which is that two major studies of hydroxychloroquine in patients who have coronavirus have shown no benefit, none. but to president trump the science doesn't matter. >> here's my evidence, i get a lot of positive calls about it. >> jeremy dime amond is out fro near the white house tonight. what have you learned today about why the president is now taking this drug, which i understand is a recent thing despite all of the evidence which exist and the studies i mentioned and others. >> reporter: right, erin. as you just laid out there's no evidence showing hydroxychloroquine is an effective treatment of coronavirus nor it's effective in preventing coronavirus infection. so there are no scientific s

. >> laura: finally, is the fda considering rescinding its warning about hydroxychloroquine, given the new information out and the study out from nyu. obviously france, huge amount of data supporting its use and it's been used a people for decades and decades in their own lives and obviously for lupus and rheumatoid arthritis. >> i can tell you the people in the fda who are here in the building with me looking very closely at hydroxychloroquine in all the potential therapeutics to attack the coronavirus. i know they are looking at many different things and if it turns out to have efficacy, i know they will examine this and move forward with it. i'm pretty sure they're looking at this very, very closely. >> laura: all right, we appreciate it. i know nih is asking for volunteers for hydroxychloroquine and azithromycin for mild to moderate cases of covid and i say about time, what took them so long? thank you for coming on tonight. a latest attempt to smear the president and discredit the potentially life saving treatments that he supports, including hydroxychloroquine. now, needless poli

>> sir, the payment is not a responsibility of the fda. i share your concern that this needs to be made available to every american. >> does anybody else want to comment on that? mr. giroir, do you think we should make that vaccine when it is created available to all regardless of income, or do you think poor and working people should be last in line for the vaccine? >> i'm sorry, senator, were you asking me? >> yes, i was, sir. yes, i was. >> no, i -- my office is one of the offices committed to serving the underserved and we need to be absolutely certain that if a vaccine or an effective therapeutic or preventive is available that it reaches all segments regardless of their ability to pay or any other social determineants of health that there may be. >> good. so what you're telling the american people today regardless of income, every american will be able to gain access to that vaccine when it comes? >> they should gain access to it. >> you represent an administration that makes that decision. >> i will certainly advocate that everyone

the fda prevented private and academic development of the chest for weeks. the cdc denied access to the functioning test, as i cited, in south korea. this created, through all the red tape and bureaucracy, to where we had to come up with a one-size-fits-all approach due to the uncertainty of the virus. and we are stuck with that now. i don't want to dwell on that necessarily, because i think those are mistakes that we've made. i'm tired of having heard that it's the administration's fault. dr. hahn, i would like to ask you this question, in that spirit of what we've talked about during your nomination process. here, going forward, will he shed some of that stodgy nest? will we look to get therapeutics and vaccines through the system in a quicker method? because i fear if we don't, if we treated through bureaucracy how we did the early period of testing, we can belabor this into the distant future. at that point, they are going to be not only the carnage from the disease itself, but from the economy, to deal with. i would like your comment on that 1-month str

we hear from fda, there is harm. for the president of the united states to serve as an example, saying i'm taking this as a preventive measure, therefore, dot, dot, dot, you american public should consider during that. this is dangerous, it's wrong, it's not the right medical approach nor the right public health approach. >> do you worry, doctor, that americans might be listening to the president rather than the doctors, the scientists, the experts at the fda? >> well, certainly. i mean, there's a danger in all of this. the good thing about hydroxychloroquine is what? it's not over the counter. so at the same time one has to find a physician who will agree to this. the reality is, i'm not sure what's going on out there anymore regarding hydroxychloroquine. and, you know, what we have to do is be able to control it by the examples we give for the american public. one, it's never been proven to work as a preventive measure. it's not working in that realm. okay. we can have the studies. but now is not the time to self e

>> wow, those judges really blasting the fda administration. says iing purell, get this, to make false claims about its hand sanitizer for 15 years. the company that makes purell claims its products prevented diseases like ebola and the flu when a smaller hand sanitizer company made the same claim, the fda took action against them but not against purell. the fda now says purell's claims are not true and could put consumers at risk by giving them a false sense of security. the judge called the fda's oversight of purell a total lack of enforcement. >>> uber eats is introducing a new feature allowing those being sent a meal to track the delivery. now in the past, only the sender could do that. so how does it work? well, let's say you send your grandmother a meal via, via, uber eats. until now, you had to let grandma know when the food was on its way. now she can track it on her own phone. >>> more and more of us are using streaming services like netflix, hulu, and disney plus and it doesn't cost some of us a dime. a new study from cordcutting.com

the president taking a drug his own fda warned against. he'll take hydroxychloroquine, but he still won't wear a mask, even though that could actually protect other people. i mean, again, it shouldn't be surprising i guess from the president after all he's been touting this drug for months. >> the fda also gave emergency authorization for hydroxychloroquine. we're having some very good things happening with it. >> it's shown very encouraging, very, very encouraging early results. >> there's some good signs. you've read the signs. i've read the signs, and i'll say it , what do you have to lose? take it. >> if things don't go as planned, it's not going to kill anybody. it will be wonderful. it'll be so beautiful. it'll be a gift from heaven. and it works. >> some other person put it forward, oh, let's go with it, you know, what do you have to lose? >> try it. if you would like. >> i've seen things that i sort of like, so what do i know, i'm not a doctor. i'm not a doctor. but i have common sense. >> okay. let me say what a president of the u

woodcock at the fda. and then a summary report from our scientists at fda, cdc, nih and barda that indicated the evidence for its benefit was weak and the evidence for its safety concerns was stronger, and they did not believe at that point it was something that should be supported. >> again, what was your reaction personally? did you think it was something worth pursuing inin ishlly when you heard from dr. woodcock? >> initially i said -- i do believe oef oh i trust dr. woodcock and her scientific judgment immensely. if she mentioned this is something we should look at, something we should consider testing in a randomized controlled clinical study, i would be supportive of the team reviewing that protocol and that information to see if it should be used. >> i understand ---ive ae heard from experts and i'm certainly not an expert in this area that the drug, the one we're talking about, in this case, hydroxychloroquine, if it's used, first of all, timely -- i understand there's a window there as far as th

let me ask the honorable fda commissioner.if god willing a vaccine is developed, and we're able to produce it as quickly as we all hope we can, i would imagine that that vaccine would be distributed to all people free of charge, to make sure at least everybody in america who needs that vaccine will get it regardless of their income. is that a fair assumption? >> senator, i certainly hope so. fda is very committed to making sure all populations in the united states, including those most vulnerable, are included in the clinical trials. >> that's not what i'm asking. what i'm saying is if and when the vaccine comes, it won't do somebody any good if they don't get it. if they have to pay a sum of money for it in order to profit the drug companies, that will not be helpful. are you guaranteeing the american people today that that vaccine will be available to all people regardless of their inco income. >> sir, the payment of vaccines isn't available to every american. >> does anybody else want to comment on that? do you think we sho

the fda's nod came after dr. anthony fauci said the trial data showed that the drug had a quote clear cut significant positive effect in diminishing the time to recovery. now, we should note this does not mean the drug should be used for all hospitalized patients. previous research suggested the drug may have potentially dangerous side effects in some patients but the maker of remdesivir, gilead sciences is hoping that they can expand the drug's use for patients earlier in the course of their illness. here is the ceo of gilead sciences on the today show. >> we were prepared and ready for this virus because of some of the work we've done with remdesivir for the past decade, and at that same time we put remdesivir in clinical trials, we made the decision before knowing it was going to be effective to expand our capacity knowing the global crisis this was and knowing we would have to be ready in the event that this turned out to be effective for patients. so we have gone from around 5,000 treatment courses to today

that his own fda is warning against. white house. what are they saying? >> we have a statement from the white house physician tonight. who said as you indicated at top that he had extensive discussions with the president about what evidence shows and concluded that the benefits out weigh the relative risk in this case. obviously the concern that everyone has about this situation is one, potential negative effects on the president health. since he is older. he does have some heart disease. common form. and hydroxychloroquine has been associated with some heart problem. also the modelling touting this drug for people who also might disregard the fda warning and seek this drug and it might be dangerous to them. what happened is the president has got feeling of the wind at his back. you have the news today the potential vaccine. you have states opening up. positive trends in the states testing rising and hepted to take the opportunity to say i told you so. i was right about hydroxychloroquine. i'm taking it and look at me i'm fine. >> doctor, to you. give me

>>recently earning fda authorization.s test by roche they do have data and their data shows that has almost 100% accuracy and so this is pretty extraordinary. >>and both in laos, us is to really reliably test a person has been infected by the coronavirus even with a nearly perfect test. there is a problem if the test shows you previously been infected and have antibodies you might have some degree of immunity to the novel coronavirus but maybe not this still open christians. >>on how long do this immunity be billy before long you're 2 years several years. believe it's you know before the immunity the city infection just listen to the scientists still need to work that out another mystery of the virus that's caused this global pandemic. >>well now to the north bay this morning where officials a marine catholic high school say they're moving forward with senior graduation plans. there will be a virtual senior ceremony it's going to take place on thursday may 28th will be on zoom. but is not taking place not taking the place